Celcuity Inc. Files Q3 2024 10-Q Report
Ticker: CELC · Form: 10-Q · Filed: Nov 14, 2024 · CIK: 1603454
Sentiment: neutral
Topics: 10-Q, financials, reporting
TL;DR
Celcuity's Q3 2024 10-Q is in. Check financials.
AI Summary
Celcuity Inc. filed its 10-Q for the period ending September 30, 2024. The company reported financial results for the third quarter and the first nine months of 2024. Specific financial figures and operational details are provided within the filing.
Why It Matters
This filing provides investors with the latest financial performance and operational updates for Celcuity Inc., crucial for understanding the company's current health and future prospects.
Risk Assessment
Risk Level: medium — 10-Q filings are standard financial reports, but the specific content can reveal significant financial health indicators or operational challenges.
Key Numbers
- 2024-09-30 — Reporting Period End Date (Indicates the end of the fiscal quarter for which financial information is reported.)
- 2024-11-14 — Filing Date (The date the 10-Q report was officially submitted to the SEC.)
Key Players & Entities
- Celcuity Inc. (company) — Filer of the 10-Q report
- 20240930 (date) — End of the reporting period
- 20241114 (date) — Filing date of the report
- MINNEAPOLIS (location) — City of Celcuity Inc.'s business and mailing address
FAQ
What is the reporting period for this 10-Q filing?
The reporting period for this 10-Q filing is the quarter ended September 30, 2024.
When was this 10-Q filed with the SEC?
This 10-Q was filed on November 14, 2024.
What is the company's name and Central Index Key (CIK)?
The company's name is Celcuity Inc., and its Central Index Key is 0001603454.
Where is Celcuity Inc. located?
Celcuity Inc.'s business and mailing address is in Minneapolis, MN.
What is the Standard Industrial Classification (SIC) code for Celcuity Inc.?
The Standard Industrial Classification code for Celcuity Inc. is 8071, which falls under SERVICES-MEDICAL LABORATORIES.
Filing Stats: 4,442 words · 18 min read · ~15 pages · Grade level 14.4 · Accepted 2024-11-14 17:00:53
Key Financial Figures
- $0.001 — nge on which registered Common Stock, $0.001 par value per share CELC The Nasdaq
Filing Documents
- form10-q.htm (10-Q) — 845KB
- ex31-1.htm (EX-31.1) — 18KB
- ex31-2.htm (EX-31.2) — 17KB
- ex32-1.htm (EX-32.1) — 7KB
- ex32-2.htm (EX-32.2) — 7KB
- 0001493152-24-046022.txt ( ) — 4321KB
- celc-20240930.xsd (EX-101.SCH) — 31KB
- celc-20240930_cal.xml (EX-101.CAL) — 45KB
- celc-20240930_def.xml (EX-101.DEF) — 127KB
- celc-20240930_lab.xml (EX-101.LAB) — 326KB
- celc-20240930_pre.xml (EX-101.PRE) — 242KB
- form10-q_htm.xml (XML) — 550KB
FINANCIAL INFORMATION
PART I. FINANCIAL INFORMATION
Financial Statements (unaudited)
ITEM 1. Financial Statements (unaudited) 3 Condensed Balance Sheets as of September 30, 2024 and December 31, 2023 3 Condensed Statements of Operations for the three months and nine months ended September 30, 2024 and 2023 4 Condensed Statements of Stockholders' Equity for the three months and nine months ended September 30, 2024 5 Condensed Statements of Stockholders' Equity for the three months and nine months ended September 30, 2023 6 Condensed Statements of Cash Flows for the nine months ended September 30, 2024 and 2023 7 Notes to Unaudited Condensed Financial Statements 8 ITEM 2. Management's Discussion and Analysis of Financial Condition and Results of Operations 17
Quantitative and Qualitative Disclosures About Market Risk
ITEM 3. Quantitative and Qualitative Disclosures About Market Risk 28
Controls and Procedures
ITEM 4. Controls and Procedures 28
OTHER INFORMATION
PART II. OTHER INFORMATION
Legal Proceedings
ITEM 1. Legal Proceedings 28
Risk Factors
ITEM 1A. Risk Factors 28
Unregistered Sales of Equity Securities and Use of Proceeds
ITEM 2. Unregistered Sales of Equity Securities and Use of Proceeds 29
Defaults Upon Senior Securities
ITEM 3. Defaults Upon Senior Securities 29
Mine Safety Disclosures
ITEM 4. Mine Safety Disclosures 29
Other Information
ITEM 5. Other Information 29
Exhibits
ITEM 6. Exhibits 30
Signatures
Signatures 31 As used in this report, the terms "we," "us," "our," "Celcuity," and the "Company" mean Celcuity Inc., unless the context indicates another meaning. 2 PART I. FINANCIAL INFORMATION ITEM 1. Financial Statements Celcuity Inc. Condensed Balance Sheets September 30, 2024 December 31, 2023 (unaudited) Assets Current Assets: Cash and cash equivalents $ 12,603,289 $ 30,662,774 Investments 251,455,468 149,919,974 Other current assets 8,379,682 10,007,849 Total current assets 272,438,439 190,590,597 Property and equipment, net 338,787 228,782 Operating lease right-of-use assets 259,744 400,019 Total Assets $ 273,036,970 $ 191,219,398 Liabilities and Stockholders' Equity: Current Liabilities: Accounts payable $ 9,158,778 $ 5,076,699 Operating lease liabilities 175,226 184,950 Accrued expenses 16,974,725 8,927,094 Total current liabilities 26,308,729 14,188,743 Operating lease liabilities 95,699 225,922 Note payable, non-current 96,923,914 37,035,411 Total Liabilities 123,328,342 51,450,076 Commitments and Contingencies (Note 5) - - Stockholders' Equity: Preferred stock, $ 0.001 par value: 2,500,000 shares authorized; 317,577 and 854,134 shares issued and outstanding as of September 30, 2024 and December 31, 2023, respectively 318 854 Common stock, $ 0.001 par value: 65,000,000 shares authorized; 37,116,267 and 25,506,012 shares issued and outstanding as of September 30, 2024 and December 31, 2023, respectively 37,116 25,506 Additional paid-in capital 384,873,261 299,818,965 Accumulated deficit ( 235,202,067 ) ( 160,076,003 ) Total Stockholders' Equity 149,708,628 139,769,322 Total Liabilities and Stockholders' Equity $ 273,036,970 $ 191,219,398 See accompanying notes to the condensed financial statements 3 Celcuity Inc. Condensed (unaudited) 2024 2023 2024 2023 Three Months Ended September 30, Nine Months Ended